Semaglutide injections belong to a group of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists, which are commonly used to manage type 2 diabetes
When evaluating compounding pharmacies, researchers should verify that the pharmacy is properly licensed, uses third-party testing for potency and purity, follows current good manufacturing practices, and has a track record of regulatory compliance
Sometimes variability in results comes from one persons bad handling introducing impurities or causing partial degradation
Nilsson-Ehle, P., Cederblad, G., Fagher, B., Monti, M., and Thysell, H
Across these trials, semaglutide treatment was associated with greater reductions in body weight and larger decreases in insulin resistance compared with placebo or active comparators